Effect of epigenetic inhibitors on lung fibroblast phenotype change in idiopathic pulmonary fibrosis
Introduction and objectives: Idiopathic Pulmonary Fibrosis (IFP) is a fatal interstitial lung disease with unknown aetiology. Lung myofibroblasts (activated fibrobalsts) are the major effector cells in the pathogenesis of IPF. Transforming growth factor-β (TGF-β1) is a potent activator of fibroblast...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Published: |
BMJ Publishing Group
2016
|
| Online Access: | https://eprints.nottingham.ac.uk/47522/ |